GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » Change In Receivables

Evolva Holding (XSWX:EVE) Change In Receivables : CHF0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Evolva Holding Change In Receivables?

Evolva Holding's change in receivables for the quarter that ended in Jun. 2023 was CHF0.00 Mil. It means Evolva Holding's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Evolva Holding's change in receivables for the fiscal year that ended in Dec. 2022 was CHF0.00 Mil. It means Evolva Holding's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

Evolva Holding's Accounts Receivable for the quarter that ended in Jun. 2023 was CHF3.03 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Evolva Holding's Days Sales Outstanding for the six months ended in Jun. 2023 was 124.34.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Evolva Holding's liquidation value for the six months ended in Jun. 2023 was CHF-9.66 Mil.

Evolva Holding Change In Receivables Historical Data

The historical data trend for Evolva Holding's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding Change In Receivables Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Evolva Holding Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding  (XSWX:EVE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Evolva Holding's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3.034/4.453*91
=124.34

2. In Ben Graham's calculation of liquidation value, Evolva Holding's accounts receivable are only considered to be worth 75% of book value:

Evolva Holding's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4.437-24.321+0.75 * 3.034+0.5 * 15.889
=-9.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding Change In Receivables Related Terms

Thank you for viewing the detailed overview of Evolva Holding's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding (XSWX:EVE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » Change In Receivables
Comparable Companies
XSWX:KNRS XSWX:SPEX XSWX:ADXN XSWX:RLF OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
ELVAF:USA EVEz:UK
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Website
https://www.evolva.com
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.